The following adverse reactions are discussed elsewhere: Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen [see Warnings and Precautions (5.2)] Hypoglycemia [seeWarnings and Precautions (5.3)] Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in clinical trials of a drug cannot be directly compared to rates in the clinical trial of another drug and may not reflect the rates observed in practice
At the lower doses most often used in metabolic and reproductive research (typically 24g per day), inositol is described as well-tolerated across reviews, with gastrointestinal discomfort reported infrequently and primarily as intake increases toward the upper end of studied ranges.12 13 When side effects do occur, they are typically: Mild Dose-related Limited to the gastrointestinal tract These effects appear more likely at higher intakes and are often manageable in practice by using lower doses or spreading intake across the day.12 13 44 However, certain groups may want to exercise additional caution
Injection: Clinical Comparison (2026) The Obesity Society Evidence-Based Obesity Treatment Guidelines
Most wellness treatments do not alter hormone production or hormone balance
Serum insulin-like growth factor 1 (IGF-1) levels, which are a substitute for GH levels, were compared to sexual function scores in 65 men who filled out the Sexual Health Inventory for Men (SHIM) and the Expanded Prostate Cancer Index Composite (EPIC) questionnaires and had their testosterone and IGF-1 levels checked
Women taking tirzepatide who use oral contraceptives should be advised that delayed gastric emptying may reduce contraceptive efficacy
